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Abstract  
Shigellosis, a disease caused by Shigella species. It is a major public health problem in developing 
nations like Nepal, where communities having poverty; poor sanitation, personal hygiene, and water 
supplies. The main aim of our study is to isolate and identify Shigella spp. from gastroenteritis patients 
and to find out its drug resistance pattern. 
A cross-sectional study was carried out based on routinely attending outpatients and inpatients.  A total 
of 225 stool samples collected from gastroenteritis patients were processed from 20 April to 24 
September 2014 in Western Regional Hospital, Pokhara, Nepal. Standard microbiological procedures 
were followed for the isolation of Shigella spp. After that slide agglutination kit method was used for 
identification of Shigella spp.  Finally, Kirby-Bauer disc diffusion method was done for an antimicrobial 
resistance test. 
Of the total 225 gastroenteritis patients, 133 were detected as bacterial positive cases.  Among positive 
cases, Shigella spp. was identified in 10.5%.  Age wise, an infection rate of Shigella in patients <15-years 
old was found higher i.e. 7.3% than in patients ≥ 15 years old i.e. 4.5% with the (p = 0.432) at 95% CI. 
The infection rate of S. dysenteriae, S. flexneri, and S. sonnei was detected in 28.6%, 57.1%, and 14.3% 
respectively. For the antimicrobial test, eight types of antibiotics were used.  The most resistance pattern 
of isolated Shigella spp. was found in nalidixic acid, and co-trimoxazole 92.8% followed by ampicillin 
64.3% and ciprofloxacin 42.8% etc.  
Our study reported that endemicity of Shigellosis with S. flexneri is the predominant group in 
gastroenteritis patients. This finding suggests that co-trimoxazole, nalidixic acid, ciprofloxacin and 
ampicillin should not be used experimentally as first-line drugs for shigellosis treatment. 
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Nepal 
*Corresponding author  
Email: balkrishabhattachan@gmail.com 
Introduction  
Shigellosis is caused by members of the 
bacterial genus Shigella. It is a severe and 
occasionally life-threatening gastrointestinal 
infection. Worldwide, Shigella spp. is the most 
common cause for acute and bloody diarrhea 
(dysentery). They are also responsible for a 
significant proportion of the burden of 
morbidity and mortality associated with 
diarrheal disease [1, 2].  The incidence of 
shigellosis in developing countries is nearly 20 
times more than in developed countries [3]. 
Annually, it is estimated that there are 125 
million infections and 14,000 deaths due to 
shigellosis in Asia. [4].  
The first emerging antimicrobial studies 
conducted in the 1950s, reported multiple drug 
resistance transmitted by plasmids among 
Shigella spp. from many countries [5, 6]. As a 
result of the considerable global burden, low 
infectious dose, clinical severity, and frequent 
reports of emerging antimicrobial resistance 
against first-line and, more recently, second-
line therapies [7-9]. Over 70% of Shigella 
isolates were resistant to two or more drugs 
including ampicillin and co-trimoxazole during 
2002 to 2007 in India [10]. Reports from 
Indonesia, Bangladesh, Malaysia and 
Nepal, showed an increasing prevalence of 
Shigella isolates that are resistant to multiple 
drugs like trimethoprim-sulphamethoxazole, 
ampicillin, nalidixic acid and tetracycline [11- 
16]. 
Shigellosis is associated with significant 
morbidity and mortality among the pre-school 
children. It is caused by any one of the four 
species of Shigella, namely Serotype A - S. 
dysenteria, Serotype B - S. flexneri, Serotype C - S. 
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sonnei, and Serotype A - S. boydii, and the 
classification is based upon the serological 
antigen [17]. The frequencies of S. flexneri, S. 
sonnei, S. boydii, and S. dysenteriae are 16.0%, 
7.0%, 2.0%, and 1.0% in developed countries 
and 60.0%, 15.0%, 6.0%, and 6.0% in developing 
countries, respectively [18]. In Nepal, Shigella 
spp. was detected in 13.6% of stool samples 
examined at Nepalgunj Medical College and 
Teaching Hospital, Banke, between September 
2011 and April 2013 [19]. The current study 
was carried out in stool specimens collected 
from gastroenteritis patients at a Tertiary Care 
Hospital in Pokhara, Nepal. The main aim of 
this study is to isolate and identify Shigella spp. 
from gastroenteritis patients and find out its 
antimicrobial resistant pattern by modified 
Kirby-Bauer disk diffusion method. 
Materials and Methods 
Study design and setting 
A cross-sectional study was conducted in 225 
stool samples collected during 20 April to 14 
September 2014. Clinical specimens of 
gastroenteritis patients were examined which is 
referred by a physician. The patient’s 
symptoms like diarrhea, abdominal pain, 
vomiting, reddish & watery stool; age, gender 
etc. were also recorded. Both outpatient and in 
patients with acute gastroenteritis but not 
undertaking any antibiotics were taken as 
subject from Western Regional Hospital. 
Sample collection  
One gram of fresh stool sample was collected in 
a clean and sterile screw-capped plastic 
container.  The collected samples were labeled 
properly with the patient’s name, age, sex, 
address, and date. These samples were 
processed immediately following Standard 
Operating Procedures (SOPs) of microbiology 
in the laboratory of Western Regional Hospital, 
Pokhara, Nepal. If there was a delay in 
processing freshly passed stool sample within 2 
hours, the specimens were kept in a 
refrigerator at 2-8oC. 
Macroscopic examination 
Microscopic physical examination of stool 
sample was done for the color, consistency 
(formed, semi-formed, unformed), presence of 
blood, mucus or pus. 
Isolation and identification of Shigella 
on Culture method:  
0.1 ml of stool sample were inoculated in 
MacConkey (MA), Xylose Lysine Deoxycholate 
(XLD) and Salmonella-Shigella (SS) agar 
(Himedia Lab. Pvt. Ltd. India) and incubated at 
37oC for 24 hours.  The suspected colonies were 
grouped as Gram Positive and Gram Negative 
by Gram’s staining reaction. Biochemically, 
Shigella are found Indole negative, Citrate 
negative, Urea negative and Hydrogen 
Sulphide negative in TSI agar’s slant and non-
motile [14]. 
Identification of Shigella spp. in slide 
agglutination test 
Shigella spp. was further tested by type-specific 
antisera of group A, B, C and D Shigella antisera 
in a serological kit (Denka Seiken Co. LTD. 3-4-
2, Nihonbashi Kayabacho, Chuo-ku, Tokyo, 
Japan). Agglutination appeared on (Group A) 
monovalent, (Group B) polyvalent, (group C) 
polyvalent and (Group D) polyvalent in Kit, 
were identified for S. dysenteriae, S. flexneri, S. 
boydii and S. sonnei respectively. 
Antibiotic susceptibility test 
Antibiotic susceptibility tests of different 
clinical isolates against various antibiotics were 
performed by modified Kirby-Bauer disk 
diffusion method in Mueller Hinton Agar (Hi-
Media Laboratories, India) according to 
Clinical Laboratory Standards Institute (CLSI) 
guidelines [20]. The antibiotics used for 
analysis were ampicillin, azithromycin, 
ciprofloxacin, co-trimoxazole, ceftriaxone, 
gentamycin, and nalidixic acid.  The diameters 
of inhibition of zone for Shigella were compared 
with strains Escherichia coli ATCC 25922 
(National Committee for Clinical Laboratory 
Sciences, Document M100-56: Sixth 
informational Supplement). 
Statistical analysis 
Pearson’s Chi-Square test was used to 
determine the significant association of 
dependent variable by using Win-pepi 
Software (Copyright J. H. Abrmson, 23 Aug 
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2016 Version 11.65) with the p-value > 0.05 is 
considered as significant at 95% CI. 
Results 
Of the total 225 gastroenteritis patients, 133 
were as detected bacterial positive cases (Gram-
positive = 54 and Gram-negative = 79). Among 
bacterial positive cases, Shigella spp. was 
detected in 10.5% (14/133).  The infection rate 
of S. flexneri, S. dysenteriae, and S. sonnei were 
detected in 57.1% (8/14), 28.6% (4/14) and 
14.3% (2/14) respectively (Figure 1).  
 
 
  
 
    
 
 
                                                                                                       
 
  
 
 
 
 
 
 
 
Sex wise distribution of all positive 
cases in different species of Shigella in 
gastroenteritis patients: 
Among bacterial positive cases, male patients 
were 129 and female patients were 96 in the 
ratio of 1.3:1. In male patients, infection rate of 
S. flexneri was the highest i.e. 42.8% (6/14), 
followed by S. dysenteriae 7.1% (1/14) and S. 
sonnei 7.1% (1/14). Whereas in female patients, 
the highest rate of infection was observed for S. 
dysenteriae, i.e. 21.1% (3/14), followed by S. 
flexneri 14.3% (2/14) and S. sonnei 7.1% (1/14) 
were depicted in figure 2.  
 
Figure 2:  Sex wise distribution of all positive cases 
in different species of Shigella in gastroenteritis 
patients. 
Age-wise distribution of 
gastroenteritis patients with Shigella 
and its infection: 
Infection rate for Shigella was 7.3% (10/137) and 
4.5% (4/88) in patient <15 years old and >15 
years old respectively, confirming that infection 
rate for Shigella spp. is higher in children 
patients than in patients elder than 15 years old 
with the p-value (p = 0.432) at 95% CI (Table 2).   
Antibiotic resistance wise distribution 
of gastroenteritis patients with 
Shigella and its species infection: 
In antibiotic resistance test, the most resistance 
pattern of isolated  Shigella  were found in 
nalidixic acid and co-trimoxazole 92.8% (13/14) 
followed by ampicillin 64.3% (9/14) and 
ciprofloxacin 42.8% (6/14), detail description of 
Shigella spp. were shown in Table 3. 
Discussion  
Worldwide, acute gastrointestinal infections 
including diarrhea are among the leading 
causes of morbidity and mortality among 
children, particularly in underdeveloped 
countries [21]. Poor access to safe water, 
inadequate sanitary conditions, lower literacy 
rate, and unavailability of healthcare facilities 
in the remote area are the major factors  
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Figure 1. Flow chart for the isolation and 
identification of Shigelle isolates. 
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predisposing diarrheal illness among 
developing countries [22].  Shigella spp. was 
detected in 10.5%, among which, infection rate 
of S. flexneri, S. dysenteriae, and S. sonnei was  
detected in 57.1%, 28.6%, and 14.3%, 
respectively in gastroenteritis patients. S. boydii 
could not identify, this might be due to small 
sample size or error in the kit method in 
diarrheal patients, or might be used by kit 
method rather than molecular methods.  In the 
previous study, it was reported that S. flexneri 
(43.2%) is the predominant of the four species 
followed by S. dysenteriae (41.5%), S. boydii 
(7.6%) and S. sonnei (7.6%) in Nepal [19].  
Similarity, the prevalence of S. flexneri is 
identified in 42.0% of isolates, while S. 
dysenteriae in 27.5%, S. boydii in 21.7% and S. 
sonnei in 8.7% in Eastern Nepal [18]. In western 
Nepal, S. flexneri, S. dysenteriae, S. boydii, and S. 
sonnei were accounted respectively for 43.1%, 
27.7%, 21.5%, and 7.7% of the total number of 
Shigella isolated [14]. 
Infection rate for Shigella spp. was higher (7.3%) 
in gastroenteritis patients of <15 years old than 
in patients ≥15 years old (4.5%) which is not 
statistically significant (p=0.432). This finding is 
consistent with the study done by Khan et al 
and Shakya et al found Shigella 42.0% and 
38.4% and 30.1% respectively [14, 18, 32]. The 
reported high prevalence of Shigella spp. from 
children aged 1-10 years, compared to the other 
age groups. They also reported high prevalence 
of Shigella spp. from male patient compared to 
the female [14, 32].  
Shigellosis or severe bacillary dysentery is a 
disease of public health importance because it 
is associated with increased mortality and 
morbidity especially among the children of 
developing countries [23]. The seasonal 
tendency of shigellosis was summer-monsoon 
[24]. Our study was conducted in summer-
monsoon (April to September); when school 
going children may get dysentery and diarrhea 
due to unsafe water like rainfall, flood and 
drinking contaminated water. On the other 
hand the no. of male cases with the pathogen 
exposer were high may be due to they go out 
from home more frequently for playing, eating 
purpose that compares to female. 
For antibiotic resistance pattern, eight types of 
antibiotics were used. Nalidixic acid and co-
trimoxazole (92.8%) was found to be the most 
resistant antibiotics in isolated Shigella spp. 
followed by ampicillin (64.3%) and 
ciprofloxacin (42.8%). Among isolated Shigella 
Spp., almost all of the S. flexneri is most resistant 
to co-trimoxazole (100.0%) while S. dysenteriae 
is resistant to nalidixic acid (100.0%). In 
addition, most of the S. sonnei was found 100.0 
% resistant in ampicillin, nalidixic acid, and co-
trimoxazole. In a study, resistance rate of 
Table 2: Age with isolated Shigella spp.; S. flexnari, S. dysenteriae, and S. sonnei in patients of gastroenteritis   
Characteristics   Total stool 
sample  
(n=225) 
Shigella  
(n=14) 
P value S. flexnari 
(n=8) 
S. dysenteriae 
(n=4) 
S. sonnei 
(n=2) 
 
P-value 
   No. (%)  No. (%) No. (%) No. (%)  
Age (year) <15  137 10 (7.3) >0.05 5 (3.6) 3 (2.1) 2 (1.4) >0.05 
 ≥15 88 4 (4.5)  3 (3.4) 1(1.3) 0 (0.0)  
         
Table 3   Antibiotic Resistance pattern of Shigella and its species     
Antibiotics S. flexnari (n=8) S. dysenteriae (n=4) S. sonnei 
(n=2) 
Total (n=14) 
 No. (%) No.  (%) No. (%) No. % 
Ampicillin (10µm) 4 (50.0) 3 (75.0) 2 (100.0) 9 (64.3) 
Azithromycin (10µm) 1 (12.5) 0 (0.0) 0 (0.0) 1 (7.1) 
Ciprofloxacin (5µm)  2 (25.0) 3 (75.0) 1 (50.0) 6 (42.8) 
Ceftriaxone (30µm) 2 (25.0) 2 (50.0) 0 (0.0) 4 (28.6) 
Co-trimoxazole (25µm)  8 (100.0) 3 (75.0) 2(100.0) 13 (92.8) 
Gentamycin (10µm) 2 (25.0) 0 (0.0) 0 (0.0) 2 (14.3) 
Nalidixic acid (30µm) 7 (87.5) 4 (100.0) 2 (100.0) 13 (92.8) 
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Shigella spp. for nalidixic acid was 95.6%, 
ampicillin 85.5%, co-trimoxazole 82.6%, 
gentamicin 24.6%, ofloxacin 21.7% etc. [19]. 
33% of the total Shigella studied was found 
multi drug resistant (MDR) i.e. they showed 
resistance to 3 or more antibiotics. However, 
none of the Shigella spp. was resistant to 
azithromycin and ceftriaxone. Ciprofloxacin 
resistance was seen only among Shigella 
dysenteriae strains [14]. Shigella spp. resistant to 
nalidixic acid (95.4%); ampicillin (84.6%) co-
trimoxazole (81.5%) and ciprofloxacin (46.2%) 
were detected in Nepal [16]. Over the past 
decades, it has been reported that a significant 
number of Shigella spp. isolates resistant to 
normally prescribed drugs [25]. In the early 
1990s, many isolates of Shigella spp. were 
susceptible to norfloxacin, nalidixic acid, 
gentamicin and furazolidone [26, 27]. However, 
in the late 1990s, most Shigella isolates showed 
an increased resistance to these antibiotics [28, 
29] but most were susceptible to ciprofloxacin 
[30]. Nowadays, alternative drugs such as the 
third generation cephalosporins are being 
commonly used. Although, the present study 
shows that Shigella strains are rapidly acquiring 
resistance to these substituted drugs as well. 
The emergence of plasmid-borne resistance to 
cephalosporins is another reason which further 
reduces the therapeutic option for the 
treatment of shigellosis [19]. Shigella spp. is 
highly necessary to start a prompt and rational 
antibiotic regimen to minimize the clinical 
effects of severe dysentery and its 
complications [31].    
We could not able to perform confirmatory 
tests like other biochemical tests, molecular 
level test like PCR, gel electrophoresis due to 
lack of resources and additional clinical 
patients issues like clinical complication and 
informed consents. Moreover, the study was 
limited to the single hospital so the results do 
not represent a broad population.  
Conclusions  
Our findings also revealed that endemicity of 
Shigellosis with S. flexneri is the predominant 
strain in gastroenteritis patients.  To prevent 
school going children from Shigellosis they 
should keep away from untreated water. As 
shown by antibiotic resistant pattern, co-
trimoxazole, nalidixic acid, ciprofloxacin,and 
ampicillin should not use experimentally as 
first-line drugs for the treatment of shigellosis.  
Frequent analysis of resistance pattern and 
periodic reporting of Shigella spp. is necessary 
for Shigellosis therapy. In addition, continuous 
cultural surveillance of multidrug-resistant test 
of Shigella spp. is necessary to know changing 
the time-to-time resistant pattern of its 
serogroup.  Isolation and sensitivity testing for 
Shigella spp. should be done regularly. 
Monitoring of emergence of resistance is highly 
recommended.  
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